Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BT-061

Known as: BT-061MAb 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Regulatory T cells (Tregs) represent a subpopulation of CD4+ T cells, which are essential for the maintenance of immunological… Expand
Is this relevant?
2016
2016
The humanized non‐depleting anti‐CD4 monoclonal antibody Tregalizumab (BT‐061) is able to selectively activate the suppressive… Expand
Is this relevant?
2015
2015
CD4+CD25+ regulatory T cells (Tregs) represent a specialized subpopulation of T cells, which are essential for maintaining… Expand
Is this relevant?
2015
2015
Regulatory T cells (Tregs) represent a subset of CD4+ T cells that express the forkhead box protein 3 factor (FOXP3) in their… Expand
Is this relevant?
2015
2015
Treatment of PBMC with the CD4-specific mAb BT-061 induces CD4 down-modulation of T cells. Here we report that addition of BT-061… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Background . Regulatory T cells (Tregs) are essential for maintaining normal immune homeostasis. We have previously reported that… Expand
Is this relevant?
2011
2011
  • M. Ehrenstein
  • Nature Reviews Drug Discovery
  • 2011
  • Corpus ID: 205477578
Pharmaceuticals have entered into an agreement to co-develop BT-061, a humanized CD4-specific monoclonal antibody that is… Expand
Is this relevant?
2010
2010
Naturally occurring Tregs are essential for maintaining normal immune homeostasis in healthy individuals. In patients with… Expand
  • figure 2
Is this relevant?